ROCK inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis.
Amides
/ pharmacology
Amyotrophic Lateral Sclerosis
/ drug therapy
Animals
Axons
/ drug effects
Disease Models, Animal
Enzyme Inhibitors
/ pharmacology
Female
Male
Mice
Mice, Transgenic
Nerve Regeneration
/ drug effects
Pyridines
/ pharmacology
Sciatic Neuropathy
/ drug therapy
Superoxide Dismutase
/ genetics
rho-Associated Kinases
/ antagonists & inhibitors
RRID:IMSR_JAX:002726
Y-27632
amyotrophic lateral sclerosis
axonal regeneration
rho kinase
Journal
The Journal of comparative neurology
ISSN: 1096-9861
Titre abrégé: J Comp Neurol
Pays: United States
ID NLM: 0406041
Informations de publication
Date de publication:
01 10 2019
01 10 2019
Historique:
received:
11
07
2018
revised:
11
02
2019
accepted:
12
02
2019
pubmed:
13
3
2019
medline:
6
10
2020
entrez:
13
3
2019
Statut:
ppublish
Résumé
Alteration of the RhoA/ROCK (Rho kinase) pathway has been shown to be neuroprotective in SOD1
Substances chimiques
Amides
0
Enzyme Inhibitors
0
Pyridines
0
Y 27632
138381-45-0
SOD1 G93A protein
EC 1.15.1.1
Superoxide Dismutase
EC 1.15.1.1
rho-Associated Kinases
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2334-2340Informations de copyright
© 2019 Wiley Periodicals, Inc.